There's a reason so many seniors wind up claiming Social Security at 62: It's the earliest age to file for benefits. But there's a downside to signing up for Social Security that young. Doing so will slash your monthly benefit for life.
As expected, Tesla (NASDAQ: TSLA) reported a record number of vehicle deliveries in its third quarter. The total number of deliveries, however, was even greater than analysts' average forecast. Fueling the quarter's growth was a huge increase in combined Model 3 and Model Y vehi
Usually, people don't bust out the scary stuff until October, but in the stock market, it was late September that spooked investors, sending stocks on a screaming decline. But while other investors are running from the tricks this month, you should be on the lookout for treats i
With October comes long-awaited third-quarter earnings. And after an eventful summer dominated by the coronavirus pandemic, those results will reveal how companies have fared during these challenging times and how their futures are affected.
There's some good news during the coronavirus pandemic: A recent survey by Schwab indicates the average amount 401(k) plan participants contributed to their accounts this year is up 20% compared with last year.
Apple is a phenomenal company by just about every measure. But with a market capitalization around $2 trillion, it's massive size makes it less appealing to investors who are looking to put their money into companies with long runways for growth.
While many investors like to talk about diversity in their portfolios, perhaps not enough attention gets paid to diversity within individual businesses. That's too bad; large businesses with multiple product lines are often safer, since if one business struggles, another segment
Boston Omaha (NASDAQ: BOMN) hasn't exactly been a standout this year. Even after a recent rebound, the young holding company's stock price is more than 21% lower than where it started 2020, dramatically underperforming the 5% gain in the S&P 500.
Vertex Pharmaceuticals (NASDAQ: VRTX) is the blueprint for a growing pharmaceutical stock. Since it went public in 1991, the company has consistently increased revenue, recording annual revenue gains the past six consecutive years.
2020 has brought a seemingly unending string of twists and turns, and the associated uncertainty has resulted in an unparalleled period of volatility for the stock market. There's a good chance that more volatility is on the way as we move into the year's final quarter, but ther
The airline industry has been battered and bruised by the COVID-19 pandemic, with travel volumes down substantially compared to last year. The airlines are all losing money right now, and with the industry not expected to make a full recovery until 2022 at the earliest carriers
Following an active September, two IPOs are scheduled to raise $200 million in the week ahead.
Several companies could join the IPO calendar early in the week, such as Spruce Biosciences (SPRB), Shattuck Labs (STTK), and Kronos Bio (KRON).
Live TV streaming platform fuboTV (FUBO
A total of 29 companies entered the public market this past week, the most ever in a single week. The week’s 11 IPOs were joined by 15 SPACs and three direct listings.
Notable new IPO filings included TPG-backed antivirus provider McAfee (MCFE), Vista Equity’s IT soft
Cerberus Telecom Acquisition, a blank check company formed by Cerberus Capital Management, filed on Friday with the SEC to raise up to $400 million in an initial public offering.
The New York, NY-based company plans to raise $400 million by offering 40 million units at $10. Each
Aspire Real Estate Investors, a multifamily REIT focused on Opportunity Zones being spun out of Avanath Capital Management, filed on Friday with the SEC to raise up to $100 million in an initial public offering.
Formed from predecessors Avanath Affordable Housing I and II, t
Tastemaker Acquisition, a blank check company focusing on the restaurant, hospitality, and related tech and services sectors, filed on Friday with the SEC to raise up to $200 million in an initial public offering.
The New York, NY-based company plans to raise $200 million by offe
Facebook Chief Executive Mark Zuckerberg and Twitter Chief Executive Jack Dorsey both agreed to voluntarily testify before the Senate Commerce Committee on Oct. 28, the companies said Friday.
Bristol Myers Squibb (NYSE: BMY) capped the week with a new approval from the Food and Drug Administration (FDA). On Friday, the regulator gave the green light for two of the pharmaceutical giant's drugs, Opdivo and Yervoy, to be used in combination to treat a form of mesothelio
Atlas Crest Investment Corp., a blank check company formed by Moelis & Company, filed on Friday with the SEC to raise up to $500 million in an initial public offering.
The New York, NY-based company plans to raise $500 million by offering 50 million units at $10. Each unit co